Persistent Chlamydia pneumoniae infection of cardiomyocytes is correlated with fatal myocardial infarction

American Journal of Pathology

Volumn 170, Issue 1, 2007, Pages 33-42

  Spagnoli, Luigi Giusto ^a   Pucci, Sabina ^a   Bonanno, Elena ^a   Cassone, Antonio ^b   Sesti, Fabiola ^a   Ciervo, Alessandra ^b   Mauriello, Alessandro ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN 2; UNCLASSIFIED DRUG; CHAPERONIN; OMP2 PROTEIN, BACTERIA;

ARTICLE; BACTERIAL INFECTION; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE CELL; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; ACUTE DISEASE; AGED; CHLAMYDIASIS; METABOLISM; MICROBIOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; T LYMPHOCYTE SUBPOPULATION;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; BACTERIAL OUTER MEMBRANE PROTEINS; CHAPERONIN 60; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; T-LYMPHOCYTE SUBSETS;

EID: 33847015314     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.051353     Document Type: Article

References (47)

1. Hansson GK: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-1695
2. Rochon PA, Tu JV, Anderson GM, Gurwitz JH, Clark JP, Lau P, Szalai JP, Sykora K, Naylor CD: Rate of heart failure and 1-year survival for older people receiving low-dose beta-blocker therapy after myocardial infarction. Lancet 2000, 356:639-644
3. Mauriello A, Sangiorgi G, Fratoni S, Palmieri G, Bonanno E, Anemona L, Schwartz RS, Spagnoli LG: Diffuse and active inflammation occurs in both vulnerable and stable plaques of the entire coronary tree a histopathologic study of patients dying of acute myocardial infarction. J Am Coll Cardiol 2005, 45:1585-1593
4. Goldstein JA, Demetriou D, Grines CL, Pica M, Shoukfeh M, O'Neill WW: Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 2000, 343:915-922
5. Spagnoli LG, Bonanno E, Mauriello A, Palmieri G, Partenzi A, Sangiorgi G, Crea F: Multicentric inflammation in epicardial coronary arteries of patients dying of acute myocardial infarction. J Am Coll Cardiol 2002, 40:1579-1588
6. Libby P: Act local, act global: inflammation and the multiplicity of "vulnerable" coronary plaques. J Am Coll Cardiol 2005, 45:1600-1602
7. Abbate A, Bonanno E, Mauriello A, Bussani R, Biondi-Zoccai GG, Liuzzo G, Leone AM, Silvestri F, Dobrina A, Baldi F, Pandolfi F, Biasucci LM, Baldi A, Spagnoli LG, Crea F: Widespread myocardial inflammation and infarct-related artery patency. Circulation 2004, 110:46-50
8. Stemme S, Faber B, Holm J, Wiklund O, Witztum JL, Hansson GK: T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci USA 1995, 92:3893-3897
9. Kol A, Bourcier T, Lichtman AH, Libby P: Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. J Clin Invest 1999, 103:571-577
10. de Boer OJ, van der Wal AC, Becker AE: Atherosclerosis, inflammation, and infection. J Pathol 2000, 190:237-243
11. Mayr M, Metzler B, Kiechl S, Willeit J, Schett G, Xu Q, Wick G: Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae: immune reactions to heat shock proteins as a possible link between infection and atherosclerosis. Circulation 1999, 99:1560-1566
12. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH, Huttunen JK, Valtonen V: Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988, 2:983-986
13. Kalayoglu MV, Libby P, Byrne GI: Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease. JAMA 2002, 288:2724-2731
14. Kuo CC, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JT: Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993, 167:841-849
15. Jackson LA, Campbell LA, Kuo CC, Rodriguez DI, Lee A, Grayston JT: Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis 1997, 176:292-295
16. Kol A, Sukhova GK, Lichtman AH, Libby P: Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. Circulation 1998, 98:300-307
17. Boman J, Hammerschlag MR: Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies. Clin Microbiol Rev 2002, 15:1-20
18. Bachmaier K, Neu N, de la Maza LM, Pal S, Hessel A, Penninger JM: Chlamydia infections and heart disease linked through antigenic mimicry. Science 1999, 283:1335-1339
19. Penninger JM, Bachmaier K: Review of microbial infections and the immune response to cardiac antigens. J Infect Dis 2000, 181(Suppl 3):S498-S504
20. Ciervo A, Visca P, Petrucca A, Biasucci LM, Maseri A, Cassone A: Antibodies to 60-kilodalton heat shock protein and outer membrane protein 2 of Chlamydia pneumoniae in patients with coronary heart disease. Clin Diagn Lab Immunol 2002, 9:66-74
21. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ, Siscovick DS, de Korte CL, Aikawa M, Juhani Airaksinen KE, Assmann G, Becker CR, Chesebro JH, Farb A, Galis ZS, Jackson C, Jang IK, Koenig W, Lodder RA, March K, Demirovic J, Navab M, Priori SG, Rekhter MD, Bahr R, Grundy SM, Mehran R, Colombo A, Boerwinkle E, Ballantyne C, Insull Jr W, Schwartz RS, Vogel R, Serruys PW, Hansson GK, Faxon DP, Kaul S, Drexler H, Greenland P, Muller JE, Virmani R, Ridker PM, Zipes DP, Shah PK, Willerson JT: From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I. Circulation 2003, 108:1664-1672
22. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM: Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vase Biol 2000, 20:1262-1275
23. Madico G, Quinn TC, Boman J, Gaydos CA: Touchdown enzyme time release-PCR for detection and identification of Chlamydia trachomatis, C. pneumoniae, and C psittaci using the 16S and 16S-23S spacer rRNA genes. J Clin Microbiol 2000, 38:1085-1093
24. Skowasch D, Yeghiazaryan K, Schrempf S, Golubnitschaja O, Welsch U, Preusse CJ, Likungu JA, Welz A, Luderitz B, Bauriedel G: Persistence of Chlamydia pneumoniae in degenerative aortic valve stenosis indicated by heat shock protein 60 homologues. J Heart Valve Dis 2003, 12:68-75
25. Rassu M, Cazzavillan S, Scagnelli M, Peron A, Bevilacqua PA, Facco M, Bertoloni G, Lauro FM, Zambello R, Bonoldi E: Demonstration of Chlamydia pneumoniae in atherosclerotic arteries from various vascular regions. Atherosclerosis 2001, 158:73-79
26. Wolf K, Fischer E, Hackstadt T: Ultrastructural analysis of developmental events in Chlamydia pneumoniae-infected cells. Infect Immun 2000, 68:2379-2385
27. Hammerschlag MR: The intracellular life of chlamydiae. Semin Pediatr Infect Dis 2002, 13:239-248
28. Gaydos CA, Summersgill JT, Sahney NN, Ramirez JA, Quinn TC: Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun 1996, 64:1614-1620
29. Fryer RH, Schwobe EP, Woods ML, Rodgers GM: Chlamydia species infect human vascular endothelial cells and induce procoagulant activity. J Invest Med 1997, 45:168-174
30. Biasucci LM, Liuzzo G, Ciervo A, Petrucca A, Piro M, Angiolillo DJ, Crea F, Cassone A, Maseri A: Antibody response to chlamydial heat shock protein 60 is strongly associated with acute coronary syndromes. Circulation 2003, 107:3015-3017
31. Benagiano M, Azzurri A, Ciervo A, Amedei A, Tamburini C, Ferrari M, Telford JL, Baldari CT, Romagnani S, Cassone A, D'Elios MM, Del Prete G: T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions. Proc Natl Acad Sci USA 2003, 100: 6658-6663
32. Benagiano M, D'Elios MM, Amedei A, Azzurri A, van der Zee R, Ciervo A, Rombola G, Romagnani S, Cassone A, Del Prete G: Human 60-kDa heat shock protein is a target autoantigen of T cells derived from atherosclerotic plaques. J Immunol 2005, 174:6509-6517
33. Danesh J, Collins R, Peto R: Chronic infections and coronary heart disease: is there a link? Lancet 1997, 350:430-436
34. Stassen FR, Vega-Cordova X, Vliegen I, Bruggeman CA: Immune activation following cytomegalovirus infection: more important than direct viral effects in cardiovascular disease? J Clin Virol 2006, 35:349-353
35. Danesh J, Peto R: Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. BMJ 1998, 316:1130-1132
36. Ott SJ, El Mokhtari NE, Musfeldt M, Hellmig S, Freitag S, Rehman A, Kuhbacher T, Nikolaus S, Namsolleck P, Blaut M, Hampe J, Sahly H, Reinecke A, Haake N, Gunther R, Kruger D, Lins M, Herrmann G, Folsch UR, Simon R, Schreiber S: Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation 2006, 113:929-937
37. Herskowitz A, Ahmed-Ansari A, Neumann DA, Beschorner WE, Rose NR, Soule LM, Burek CL, Sell KW, Baughman KL: Induction of major histocompatibility complex antigens within the myocardium of patients with active myocarditis: a nonhistologic marker of myocarditis. J Am Coll Cardiol 1990, 15:624-632
38. Wojnicz R, Nowalany-Kozielska E, Wodniecki J, Szczurek-Katanski K, Nozynski J, Zembala M, Rozek MM: Immunohistological diagnosis of myocarditis. Potential role of sarcolemmal induction of the MHC and ICAM-1 in the detection of autoimmune mediated myocyte injury. Eur Heart J 1998, 19:1564-1572
39. Wang G, Burczynski F, Hasinoff B, Zhong G: Infection of myocytes with chlamydiae. Microbiology 2002, 148:3955-3959
40. Redecke V, Dalhoff K, Bohnet S, Braun J, Maass M: Interaction of Chlamydia pneumoniae and human alveolar macrophages: infection and inflammatory response. Am J Respir Cell Mol Biol 1998, 19:721-727
41. Giordano FJ: Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 2005, 115:500-508
42. Grayston JT, Kronmal RA, Jackson LA, Parisi AF, Muhlestein JB, Cohen JD, Rogers WJ, Crouse JR, Borrowdale SL, Schron E, Knirsch C: Azithromycin for the secondary prevention of coronary events. N Engl J Med 2005, 352:1637-1645
43. Cannon CP, Braunwald E, McCabe CH, Grayston JT, Muhlestein B, Giugliano RP, Cairns R, Skene AM: Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome. N Engl J Med 2005, 352:1646-1654
44. Gieffers J, Fullgraf H, Jahn J, Klinger M, Dalhoff K, Katus HA, Solbach W, Maass M: Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment. Circulation 2001, 103:351-356
45. Katz JT, Shannon RP: Bacteria and coronary atheroma: more fingerprints but no smoking gun. Circulation 2006, 113:920-922
46. Anderson JL: Infection, antibiotics, and atherothrombosis - end of the road or new beginnings? N Engl J Med 2005, 352:1706-1709
47. Kuhl U, Pauschinger M, Seeberg B, Lassner D, Noutsias M, Poller W, Schultheiss HP: Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 2005, 112:1965-1970